West Family Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.35M Buy
12,197
+2,558
+27% +$284K 0.35% 56
2025
Q1
$1.08M Hold
9,639
0.41% 49
2024
Q4
$890K Sell
9,639
-165
-2% -$15.2K 0.31% 65
2024
Q3
$822K Buy
9,804
+50
+0.5% +$4.19K 0.28% 71
2024
Q2
$669K Sell
9,754
-1,227
-11% -$84.2K 0.2% 88
2024
Q1
$804K Buy
10,981
+101
+0.9% +$7.4K 0.25% 77
2023
Q4
$881K Sell
10,880
-503
-4% -$40.7K 0.3% 63
2023
Q3
$853K Sell
11,383
-504
-4% -$37.8K 0.3% 67
2023
Q2
$916K Buy
+11,887
New +$916K 0.36% 63
2023
Q1
Sell
-11,870
Closed -$1.02M 231
2022
Q4
$1.02M Sell
11,870
-830
-7% -$71.3K 0.35% 61
2022
Q3
$783K Buy
12,700
+1,981
+18% +$122K 0.33% 67
2022
Q2
$663K Buy
10,719
+6,144
+134% +$380K 0.26% 76
2022
Q1
$272K Sell
4,575
-9,440
-67% -$561K 0.08% 207
2021
Q4
$1.02M Sell
14,015
-2,939
-17% -$213K 0.28% 65
2021
Q3
$1.18M Buy
16,954
+3,659
+28% +$256K 0.31% 55
2021
Q2
$915K Buy
+13,295
New +$915K 0.25% 59